Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-31T14:26:42.746Z Has data issue: false hasContentIssue false
  • English
  • Français

Pimozide as a Neuroleptic

Published online by Cambridge University Press:  29 January 2018

Hugh Freeman
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Comments
Information
The British Journal of Psychiatry , Volume 135 , Issue 1 , July 1979 , pp. 82 - 83
Copyright
Copyright © The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Costall, B. & Naylor, R. J. (1977) Behavioural characterization of neuroleptic properties in the rodent. Proceedings of the Royal Society of Medicine, 70, Supplement 10, 5–14.Google Scholar
Falloon, I., Watt, D. C. & Shepherd, M. (1978a) A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia. Psychological Medicine, 8, 59–70.CrossRefGoogle ScholarPubMed
Falloon, I., Watt, D. C. & Shepherd, M. (1978b) The social outcome of patients in a trial of long-term continuation therapy in schizophrenia; pimozide vs fluphenazine. Ibid, 265–74.Google Scholar
Gibson, A. C. (1978) Depot injections and tardive dyskinesia. British Journal of Psychiatry, 132, 361–5.Google Scholar
Hogarty, G. E. (1979) In Management of Schizophrenia: Biological and Sociological Aspects (ed. Van Praag, H. M.). Utrecht (in the press).Google Scholar
Jimerson, D. C., Post, R. M., Skyler, J. & Bunney, W. E. Jr. (1976) Prolactin in cerebrospinal fluid and dopamine function in men. Journal of Pharmacy and Pharmacology, 28, 845–6.Google Scholar
McCreadie, R. G., Heykants, J. J. P., Chalmers, A. & Anderson, A. M. (1979) Plasma pimozide profiles in chronic schizophrenics. British Journal of Clinical Pharmacology (in the press).Google Scholar
Pinder, R. M., Brogden, R. N., Sawyer, P. R., Speight, T. M., Spencer, R. & Avery, G. S. (1976) Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry. Drugs, 12, 1–40.Google Scholar
Piyakulmala, S., Corbett, L., Akluwalia, Y., Berry, R. A. & Meltzer, H. Y. (1977) High dose pimozide in the treatment of acutely agitated schizophrenia. Current Therapeutic Research, 22, 453–61.Google Scholar
Reilly, T. M., Jopling, W. H. & Beard, A. W. (1978) Successful treatment with pimozide of delusional parasitosis. British Journal of Dermatology, 98, 457–9.Google ScholarPubMed
Riding, B. E. J. & Munro, A. (1975) Lancet, i, 400.Google Scholar
Ross, M. S. & Moldofsky, H. (1978) A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's Syndrome. American Journal of Psychiatry, 135, 585–7.Google ScholarPubMed
Shopsin, B. & Selzer, G. (1977) High-dose pimozide in actuely ill, newly admitted schizophrenic patients. Current Therapeutic Research, 21, 755–67.Google Scholar
Watt, D. C. (1978) Maintenance drugs for schizophrenia (letter). Lancet, ii, 1045–6.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.